Scope creep in healthcare AI adoption
The rapid deployment of AI for low-risk medical tasks, like prescription refills, risks leading to 'scope creep' where AI is quickly granted clinical decision-making power without established legal accountability.
The argument
The discussion focused on Utah's pilot programs allowing AI to renew prescriptions, noting that while it offers cost and efficiency savings, it blindsided medical boards and leaves malpractice liability legally unresolved.
The thesis, stress-tested
✓ What validates it
- ✓Court rulings establishing liability for AI medical errors
- ✓Expansion of AI clinical decision-making into higher-risk medical specialties
▸ Risks discussed
- ▸Unresolved malpractice and liability frameworks
- ▸Potential patient harm from unreviewed AI clinical decisions
- ▸Pushback from state medical licensing boards
Hear it yourself
"The concern is that you can get in with companies that do not end up having sort of the protections you'd expect from a bank. Many of these crypto companies in particular are not looking to be FDIC insured, which means that assets you place with them, if you lose them, there's no insurance there as a backstop. So that's the core concern. Yeah. As always, consult your own financial advisor on this one. Stacy Cowley with the New York Times. Stacy, thanks a lot. I appreciate your time. Thanks. Today being a day that ends in why there is news of"